Endotoxin pp 389-398 | Cite as

Mechanisms of Endotoxin Stimulation of Monocytes in Whole Blood

  • B. Osterud
  • J. O. Olsen
  • L. Wilsgard
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 256)


Bacterial lipopolysaccharide endotoxins are potent inflammatory agents that have many physiologic and biochemical effects in vivo. Although a wide variety of biological responses to endotoxin have been well characterized, the molecular mechanism by which endotoxin influences cellular functions is still not established.


Disseminate Intravascular Coagulation Platelet Rich Plasma Blood Monocyte High Responder Lipoxygenase Inhibitor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Broze, Jr., G. J., 1982, Binding of human factor VII and VIIa to monocytes. J. Clin. Invest. 70: 526.Google Scholar
  2. 2.
    Dennis, E. A., 1987, Regulation of eicosanoid production: Role of phospholipases and inhibitors. Bio/Technology 5: 362.Google Scholar
  3. 3.
    Edwards, R. L., and Perla, D., 1984, The effect of serum on monocyte tissue factor generation. Blood 64: 707.PubMedGoogle Scholar
  4. 4.
    Friberger, P., Knos, M., and Mellstrom, L., 1982, in: “Endotoxins and their detection with the limulus amebocyte lysate test”. S. W. Watson, J. Lewin and T. J. Novitsky, eds. Alan R. Liss Publishing New York.Google Scholar
  5. 5.
    Garner, R., Chater, B. V., and Brown, D. L., 1974, The role of complement in endotoxin shock and dissemianted intravascular coagulation: experimental observations in the dog. Brit. J. Haematol. 28: 393.Google Scholar
  6. 6.
    Gerrity, R. G., 1981, The role of the monocyte in atherogenesis. I. Transition of blood borne monocytes into foam cells in fatty lesions. Am. J. Pathol. 103: 181.Google Scholar
  7. 7.
    Haeffner-Cavaillon, N., Cavaillon, J.-M., Etievant, M., Lebbar, S., and Szabo, L., 1985, Specific binding of endotoxin to human monocytes and mouse macrophages: serum requirement. Cellular Immunol. 91: 119.CrossRefGoogle Scholar
  8. 8.
    Hetland, G., Johnson, E., and Aasebo, U., 1986, Human alveolar macrophages synthesize the functional alternative pathway of complement and active C5 and C9 in vitro. Scand. J. Immunol. 24: 603.Google Scholar
  9. 9.
    Lorenzet, R., Niemetz, J., Marcus, A. J., and Brockman, M. J., 1986, Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatetraenoic acid. J. Clin. Invest. 78: 418.Google Scholar
  10. 10.
    McCartney, A. C., Banks, J. G., Clements, G. B., Sleigh, J. D., Tehrani, M., and Ledeingham, I. McA., 1j983, Endotoxinemia in septic shock: Clinical and post mortem correlations. Intensive Care Med. 9: 117.Google Scholar
  11. 11.
    Morrison, D. C., and Cline, L., 1977, Activation of the classical and properidin pathways of complement by bacterial lipopolysaccharides (LPS). J. Immunol. 48: 362.Google Scholar
  12. 12.
    Niemetz, J., and Marcus, A. J., 1974, The stimulatory effect of platelets and platelet membranes on the procoagulant effect of leukocytes. J. Clin. Invest. 54: 1437.Google Scholar
  13. 13.
    Osterud, B., Bogwald, J., Llndahl, U., and Seljelid, R., 1981, Production of blood coagulation factor V and tissue thromboplastin by macrophages in vitro. FEBS Letters 127: 154.PubMedCrossRefGoogle Scholar
  14. 14.
    Osterud, B., and Bjorklid, E., 1982. Factor VII associated with monocytes in endotoxin stimulated blood. Biochem. Biophys. Res. Commun. 108: 620Google Scholar
  15. 15.
    Osterud, B., and Eskeland, T., 1982, The mandatory role of complement in the endotoxin-induced synthesis of tissue thromboplastin in blood monocytes. FEBS Letters 149: 75.PubMedCrossRefGoogle Scholar
  16. 16.
    Osterud, B., and Bjorklid, E., 1982, The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. Scand. J. Haematol. 29: 175.Google Scholar
  17. 17.
    Osterud, B., and Flaegstad, T., 1983, Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection related to an unfavourable prognosis. Thromb. Haemostas. 49: 5.Google Scholar
  18. 18.
    Osterud, B., 1984, Activation pathway of the coagulation system in normal haemostasis (Review). Scand. J. Haematol. 32: 337.Google Scholar
  19. 19.
    Pick, E., and Bromberg, Y., 1982, Quo Vadis macrophage activation. Role of phospholipids in the elicitation of the oxidative burst in macrophages. Transpl. Procd. 14: 570.Google Scholar
  20. 20.
    Prydz, H., and Lyberg, T., 1980, Effect of some drugs on thromboplastin (Factor III) activity of human monocytes in vitro. Biochem. Pharmacol. 29: 9.Google Scholar
  21. 21.
    Rivers, R. P. A., Hathaway, W. E., and Weston, W. L., 1975, The endotoxin-induced coagulant activity of human monocytes. Brit. J. Haematol. 30: 311.Google Scholar
  22. 22.
    Tenner, A. J., Leshavre, P. H., and Cooper, N. R., 1981, Purification and radiolabeling of human Clq. J. Immunol. 127: 648.PubMedGoogle Scholar
  23. 23.
    van Lenten, B. J., Fogelman, A. M., Haberland, M. E., and Edwards, P. E., 1986, The role of lipoproteins and rececptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc. Nat’l. Acad. Sci. 83: 2704.Google Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • B. Osterud
    • 1
  • J. O. Olsen
    • 1
  • L. Wilsgard
    • 1
  1. 1.Institute of Medical BiologyUniversity of TromsoTromsoNorway

Personalised recommendations